Decreased regulatory T cells in vulnerable atherosclerotic lesions: Imbalance between pro- and anti-inflammatory cells in atherosclerosis

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Rohm, Ilonka ^a   Atiskova, Yevgeniya ^a   Drobnik, Stefanie ^a   Fritzenwanger, Michael ^a   Kretzschmar, Daniel ^a   Pistulli, Rudin ^a   Zanow, Jürgen ^a   Krönert, Thomas ^b   Mall, Gita ^a   Figulla, Hans Reiner ^a   Yilmaz, Atilla ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Orthopaedics and Trauma Surgery Thüringen Klinik Saalfeld   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD123 ANTIGEN; CD161 ANTIGEN; CD209 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CD83 ANTIGEN; FASCIN; HLA DR ANTIGEN; PROTEIN S 100; TRANSCRIPTION FACTOR FOXP3; ACTIN BINDING PROTEIN; CARRIER PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; HELPER CELL; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED;

AGED; ANTIGENS, CD; ATHEROSCLEROSIS; CARRIER PROTEINS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INFLAMMATION; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY;

EID: 84947649509     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/364710     Document Type: Article

References (33)

1. C. Weber and H. Noels, "Atherosclerosis: current pathogenesis and therapeutic options, " Nature Medicine, vol. 17, no. 11, pp. 1410-1422, 2011.
2. A. Niessner, K. Sato, E. L. Chaikof, I. Colmegna, J. J. Goronzy, and C. M. Weyand, "Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-, " Circulation, vol. 114, no. 23, pp. 2482-2489, 2006.
3. J. W. Han, K. Shimada, W. Ma-Krupa et al., "Vessel wallembedded dendritic cells induce T-cell autoreactivity and initiate vascular inflammation, " Circulation Research, vol. 102, no. 5, pp. 546-553, 2008.
4. D. Hawiger, K. Inaba, Y. Dorsett et al., "Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo, " The Journal of Experimental Medicine, vol. 194, no. 6, pp. 769-779, 2001.
5. K. Kretschmer, I. Apostolou, D. Hawiger, K. Khazaie, M. C. Nussenzweig, and H. von Boehmer, "Inducing and expanding regulatory T cell populations by foreign antigen, " Nature Immunology, vol. 6, no. 12, pp. 1219-1227, 2005.
6. A. Mor, D. Planer, G. Luboshits et al., "Role of naturally occurring CD4+CD25+ regulatory T cells in experimental atherosclerosis, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 4, pp. 893-900, 2007.
7. R. Klingenberg, N. Gerdes, R. M. Badeau et al., "Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis, " The Journal of Clinical Investigation, vol. 123, no. 3, pp. 1323-1334, 2013.
8. A. K. Robertson, M. Rudling, X. Zhou, L. Gorelik, R. A. Flavell, and G. K. Hansson, "Disruption of TGF-signaling in T cells accelerates atherosclerosis, " Journal of Clinical Investigation, vol. 112, no. 9, pp. 1342-1350, 2003.
9. J. F. Toole, "ACAS recommendations for carotid endarterectomy, " The Lancet, vol. 347, no. 8994, article 121, 1996.
10. H. J. M. Barnett, D. W. Taylor, M. Eliasziw et al., "Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis, " The New England Journal of Medicine, vol. 339, no. 20, pp. 1415-1425, 1998.
11. L. Norgren, W. R. Hiatt, J. A. Dormandy, M. R. Nehler, K. A. Harris, and F. G. R. Fowkes, "Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II), " Journal of Vascular Surgery, vol. 33, supplement 1, pp. S1-S75, 2007.
12. H. C. Stary, A. B. Chandler, R. E. Dinsmore et al., "A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report fromtheCommittee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 15, no. 9, pp. 1512-1531, 1995.
13. A. Yilmaz, M. Lochno, F. Traeg et al., "Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques, " Atherosclerosis, vol. 176, no. 1, pp. 101-110, 2004.
14. M. Naghavi, P. Libby, E. Falk et al., "From vulnerable plaque to vulnerable patient: a call for newdefinitions and risk assessment strategies: Part I, " Circulation, vol. 108, no. 14, pp. 1664-1672, 2003.
15. R. Virmani, F. D. Kolodgie, A. P. Burke et al., "Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 10, pp. 2054-2061, 2005.
16. G. K. Hansson and A. Hermansson, "The immune system in atherosclerosis, " Nature Immunology, vol. 12, no. 3, pp. 204-212, 2011.
17. R. M. Steinman and M. C. Nussenzweig, "Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance, " Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 1, pp. 351-358, 2002.
18. E. Profumo, B. Buttari, M. E. Tosti et al., "Plaque-infiltrating T lymphocytes in patients with carotid atherosclerosis: an insight into the cellular mechanisms associated to plaque destabilization, " Journal of Cardiovascular Surgery, vol. 54, no. 3, pp. 349-357, 2013.
19. Y. V. Bobryshev and R. S. Lord, "Co-accumulation of dendritic cells and natural killer T cells within rupture-prone regions in human atherosclerotic plaques, " Journal of Histochemistry andCytochemistry, vol. 53, no. 6, pp. 781-785, 2005.
20. M. B. Lutz and G. Schuler, "Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?" Trends in Immunology, vol. 23, no. 9, pp. 445-449, 2002.
21. R. M. Steinman, D. Hawiger, K. Liu et al., "Dendritic cell function in Vivo during the steady state: a role in peripheral tolerance, " Annals of the New York Academy of Sciences, vol. 987, pp. 15-25, 2003.
22. G. Penna, M. Vulcano, S. Sozzani, and L. Adorini, "Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells, " Human Immunology, vol. 63, no. 12, pp. 1164-1171, 2002.
23. S. Pichyangkul, T. P. Endy, S. Kalayanarooj et al., "A blunted blood plasmacytoid dendritic cell response to an acute systemic viral infection is associated with increased disease severity, " The Journal of Immunology, vol. 171, no. 10, pp. 5571-5578, 2003.
24. B. Legein, L. Temmerman, E. A. L. Biessen, and E. Lutgens, "Inflammation and immune system interactions in atherosclerosis, " Cellular and Molecular Life Sciences, vol. 70, no. 20, pp. 3847-3869, 2013.
25. Y. V. Bobryshev and R. S. A. Lord, "S-100 positive cells in human arterial intima and in atherosclerotic lesions, " Cardiovascular Research, vol. 29, no. 5, pp. 689-696, 1995.
26. M. Yadav, C. Louvet, D. Davini et al., "Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo, " The Journal of Experimental Medicine, vol. 209, no. 10, pp. 1713-1722, 2012.
27. O. J. de Boer, J. J. van der Meer, P. Teeling, C. M. van der Loos, and A. C. van derWal, "Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions, " PLoS ONE, vol. 2, no. 8, article e779, 2007.
28. S. Patel, S. H. Chung, G. White, S. Bao, and D. S. Celermajer, "The "atheroprotective" mediators apolipoproteinAI and Foxp3 are over-abundant in unstable carotid plaques, " International Journal of Cardiology, vol. 145, no. 2, pp. 183-187, 2010.
29. B. Dietel, I. Cicha, C. J. Voskens, E. Verhoeven, S. Achenbach, and C. D. Garlichs, "Decreased numbers of regulatory T cells are associated with human atherosclerotic lesion vulnerability and inversely correlate with infiltrated mature dendritic cells, " Atherosclerosis, vol. 230, no. 1, pp. 92-99, 2013.
30. C. Weber, A. Schober, and A. Zernecke, "Key regulators of mononuclear cell recruitment in atherosclerotic vascular disease, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 11, pp. 1997-2008, 2004.
31. J. George, "Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis, " Nature Clinical Practice Cardiovascular Medicine, vol. 5, no. 9, pp. 531-540, 2008.
32. W. Peeters, W. E. Hellings, D. P. V. De Kleijn et al., "Carotid atherosclerotic plaques stabilize after stroke insights into the natural process of atherosclerotic plaque stabilization, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 1, pp. 128-133, 2009.
33. M. Crisby, G. Nordin-Fredriksson, P. K. Shah, J. Yano, J. Zhu, and J. Nilsson, "Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization, " Circulation, vol. 103, no. 7, pp. 926-933, 2001.